The World Web Times - The News And Times

Sites

GSK to Buy CureVac’s Covid-19, Flu Vaccine Rights for Up to $1.56 Billion – The Wall Street Journal

Post author By Mike Nova
Post date July 3, 2024

GSK to Buy CureVac’s Covid-19, Flu Vaccine Rights for Up to $1.56 Billion The Wall Street Journal

The post GSK to Buy CureVac’s Covid-19, Flu Vaccine Rights for Up to $1.56 Billion – The Wall Street Journal first appeared on The CoronaVirus Alerts – The News And Times.